# Primary Prevention of Hypertension in Obese Adolescents

> **NCT00288158** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 60 (actual)

## Conditions studied

- Obesity
- Pre-Hypertension
- Hyperuricemia

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Probenecid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00288158
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288158, "Primary Prevention of Hypertension in Obese Adolescents". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00288158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*